Publication | Open Access
A Bivalent Omicron-Containing Booster Vaccine against Covid-19
638
Citations
18
References
2022
Year
The bivalent omicron-containing vaccine mRNA-1273.214 elicited neutralizing antibody responses against omicron that were superior to those with mRNA-1273, without evident safety concerns. (Funded by Moderna; ClinicalTrials.gov number, NCT04927065.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1